In the last trading session, 2.31 million Cabaletta Bio Inc (NASDAQ:CABA) shares changed hands as the company’s beta touched 2.78. With the company’s per share price at $2.48 changed hands at $0.3 or 13.76% during last session, the market valuation stood at $125.84M. CABA’s last price was a discount, traded about -444.35% off its 52-week high of $13.50. The share price had its 52-week low at $0.99, which suggests the last value was 60.08% up since then.
Analysts gave the Cabaletta Bio Inc (CABA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.36. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CABA as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight.
Cabaletta Bio Inc (NASDAQ:CABA) trade information
Instantly CABA was in green as seen at the end of in last trading. With action 32.62%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 9.25%, with the 5-day performance at 32.62% in the green. However, in the 30-day time frame, Cabaletta Bio Inc (NASDAQ:CABA) is 113.79% up.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 82.29% from its current market value. According to analyst projections, CABA’s forecast low is 3 with 32 as the target high. To hit the forecast high, the stock’s price needs a -1190.32% plunge from its current level, while the stock would need to soar -20.97% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -20.35%. The 2025 estimates are for Cabaletta Bio Inc earnings to decrease by -5.46%, but the outlook for the next 5-year period is at 3.54% per year.
CABA Dividends
Cabaletta Bio Inc is expected to release its next quarterly earnings report in July.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 9.6469% or 4.76 million shares worth $35.58 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were T. Rowe Price Small-Cap Value Fund, Inc. and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 1.93 shares estimated at $4.79 million under it, the former controlled 3.81% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.76% of the shares, roughly 1.4 shares worth around $3.47 million.
